It can be hard to tell if you have Parkinson's disease.

Here are the 10 signs you might have the disease. No single one of these signs means that you shouldworry. But if you have morethan one symptom you should make an appointment to talk to yourdoctor.

Have you noticed a slight shaking or tremor in your finger, thumb, hand, chin or lip? Does your leg shake when you sit down or relax? Twitching or shaking of limbs is a common early sign of Parkinson's disease.

Shaking can be normal after lots of exercise or if you have been injured. Shaking could also be caused by a medicine you take.

Has your handwriting suddenly gotten much smaller than in it was in the past? You may notice the way you write words on a page has changed, such as letter sizes are smaller and the words are crowded together. A sudden change in handwriting is often a sign of Parkinson's disease.

Sometimes writing can change as you get older, if you have stiff hands or fingers or poor vision, but this happens over time and not suddenly.

Have you noticed you no longer smell certain foods very well? If you seem to have more trouble smelling foods like bananas, dill pickles or licorice, you should ask your doctor about Parkinson's disease.

Your sense of smell can be changed by a cold, flu or a stuffy nose, but it should come back after you are better.

Do you thrash around in bed or kick and punch while you are deeply asleep? You might notice that you started falling out of bed while asleep. Sometimes, your spouse will notice, or will want to move to another bed. Sudden movements during sleep may be a sign of Parkinson's disease.

It is normal for everyone to have a night when they 'toss and turn' instead of sleeping.

Do you feel stiff in your body, arms or legs? Sometimes stiffness goes away as you move. If it does not, it can be a sign of Parkinson's disease. You might notice that your arms don't swing when you walk, or maybe other people have said you look stiff. An early sign might be stiffness or pain in your shoulder or hips. People sometimes say their feet seem 'stuck to the floor.'

If you have injured your arm or shoulder, you may not be able to use it as well until it is healed, or another illness like arthritis might cause the same symptom.

Do you have trouble moving your bowels without straining every day? Straining to move your bowels can be an early sign of Parkinson's disease and you should talk to your doctor.

If you do not have enough water or fiber in your body, it can cause problems in the bathroom. Alsosome medicine will cause constipation. If there is no other reason such as diet or medicine that would cause you to have trouble moving your bowels, you should speak with your doctor.

Have other people told you that your voice is very soft when you speak in a normal tone, or that you sound hoarse? If there has been a change in your voice you should see your doctor about whether it could be Parkinson's disease. Sometimes you might think other people are losing their hearing, when really you are speaking more softly.

A chest cold or other virus can cause your voice to sound different, but you should go back to sounding the same when you get over your cough or cold.

Have you been told that you have a serious, depressed or mad look on your face more often, even when you are not in a bad mood? This serious-looking face is called masking. Also, if you or other people notice that you have a blank stare or do not blink your eyes very often, you should ask your doctor about Parkinson's disease.

Some medicines can cause you to have the same type of serious or staring look, but you would go back to the way you were after you stopped the medication.

Do you notice that you often feel dizzy when you stand up out of a chair? Feeling dizzy or fainting can be signs of low blood pressure and can be linked to Parkinson's disease.

Everyone has had a time when they stood up and felt dizzy, but if it happens on a regular basis you should see your doctor.

Are you not standing up as straight as you used to? If you or your family or friends notice that you seem to be stooping, leaning or slouching when you stand, it could be a sign of Parkinson's disease.

If you have pain from an injury or if you are sick, it might cause you to stand crookedly. Also, a problem with your bones can make you hunch over.

For more information, visit our Treatment page.

Watch and share this public service announcement featuring U.S. Senator Cory Booker that discusses the early warning signs of Parkinson's disease.

Made possible through the generous support of the Medtronic Foundation and thousands of people with Parkinson's and their families.

<< Back to Understanding Parkinson's

View post:
10 Early Warning Signs of Parkinson's Disease | National ...

Parkinson's disease is one of a larger group of neurological conditions called motor system disorders. Historians have found evidence of the disease as far back as 5000 B.C. It was first described as "the shaking palsy" in 1817 by British doctor James Parkinson. Because of Parkinson's early work in identifying symptoms, the disease came to bear his name.

In the normal brain, some nerve cells produce the chemical dopamine, which transmits signals within the brain to produce smooth movement of muscles. In Parkinson's patients, 80 percent or more of these dopamine-producing cells are damaged, dead, or otherwise degenerated. This causes the nerve cells to fire wildly, leaving patients unable to control their movements. Symptoms usually show up in one or more of four ways:

Though full-blown Parkinson's can be crippling or disabling, experts say early symptoms of the disease may be so subtle and gradual that patients sometimes ignore them or attribute them to the effects of aging. At first, patients may feel overly tired, "down in the dumps," or a little shaky. Their speech may become soft and they may become irritable for no reason. Movements may be stiff, unsteady, or unusually slow.

Original post:
Parkinsons Disease Information from Parkinsons.org

Every Parkinson's patient experiences a combination of three motor symptoms, which typically worsen over time at a pace that varies from person to person. For most people, symptoms begin on one side of the body and later spread to the other side.

Classic symptoms of Parkinson's disease may include:

Tremor is usually the first symptom people notice, and unlike other tremors, these tremors are typically present when the patient is at rest. Emotional and physical stress tends to make the tremor worse. Sleep, complete relaxation and intentional movement or action usually reduce or stop the tremor. It is important to remember, however, that as many as 30 percent or more of people with Parkinson's disease do not experience tremors.

The muscles of the legs, face, neck or other parts of the body may become unusually stiff or rigid. Another common early sign of the disease is a reduced swing of the arm on one side when the person is walking.

In addition to the four classic motor symptoms, Parkinson's disease can cause a variety of other disabilities as the disease progresses:

Finally, people with Parkinson's disease may experience one or more symptoms that typically do not affect their movements. The most typical nonmotor symptoms of Parkinson's disease include:

A person with Parkinson's disease may slowly become more dependent, fearful, indecisive and passive. The person may talk less often, withdraw from people and be inactive unless encouraged to move about. Depression is very common with this disease and can be caused by chemical changes in the brain. Symptoms of depression often improve with proper treatment.

The causes for most forms of Parkinson's disease are unknown. Some evidence indicates that inherited (genetic) factors may predispose some people to develop Parkinson's disease; however, the majority of people with Parkinson's don't have a known gene abnormality. Research has indicated that there may be a connection between Parkinson's and environmental toxins that damage dopamine-producing nerves.

Read the rest here:
Parkinson's Disease - Cedars-Sinai

There is no cure for Parkinson disease, but treatment can help control your symptoms.

MEDICINE

Your health care provider will prescribe medicines to help control your shaking and movement symptoms. These drugs work by increasing dopamine in your brain.

At certain times during the day, the medicine often wears off and symptoms can return. If this happens, your health care provider may need to change the:

You may also need to take medicines to help with:

Parkinson medicines can cause severe side effects, including:

Tell your doctor right away if you have these side effects. Never change or stop taking any medicines without talking with your doctor. Work with your doctors and other providers to find a treatment plan that works for you.

As the disease gets worse, symptoms such as stooped posture, frozen movements, and speech problems may not respond to the medicines.

SURGERY

Surgery may be an option for some people. Surgery does not cure Parkinson disease, but itmay help ease symptoms. Types of surgery include:

LIFESTYLE

Certain lifestyle changesmay help you cope with Parkinson disease:

View original post here:
Parkinson disease: MedlinePlus Medical Encyclopedia

About Parkinson's disease dementia

The brain changes caused by Parkinson's disease begin in a region that plays a key role in movement. As Parkinson's brain changes gradually spread, they often begin to affect mental functions, including memory and the ability to pay attention, make sound judgments and plan the steps needed to complete a task.

The key brain changes linked to Parkinson's disease and Parkinson's disease dementia are abnormal microscopic deposits composed chiefly of alpha-synuclein, a protein that's found widely in the brain but whose normal function isn't yet known. The deposits are called "Lewy bodies".

Lewy bodies are also found in several other brain disorders, including dementia with Lewy bodies (DLB). Evidence suggests that dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia may be linked to the same underlying abnormalities in brain processing of alpha-synuclein.

Another complicating factor is that many people with both dementia with Lewy bodies and Parkinson's disease dementia also have plaques and tangles hallmark brain changes linked to Alzheimer's disease.

Parkinson's disease is a fairly common neurological disorder in older adults, estimated to affect nearly 2 percent of those older than age 65. The National Parkinson Foundation estimates that 1 million Americans have Parkinson's disease. It is estimated that 50 to 80 percent of those with Parkinson's disease eventually experience Parkinson's disease dementia. Sign up for our enews to receive updates about Alzheimers and dementia care and research.

Learn more: Dementia with Lewy Bodies, Mixed Dementia

What percentage of people with Parkinson's develop dementia?

An estimated 50 to 80 percent of those with Parkinson's eventually experience dementia as their disease progresses. The average time from onset of Parkinson's to developing dementia is about 10 years.

Parkinson's disease dementia is a decline in thinking and reasoning that develops in someone diagnosed with Parkinson's disease at least a year earlier. Common symptoms include:

Sign up for our weekly e-newsletter

As with other types of dementia there is no single test or any combination of tests that conclusively determines that a person has Parkinson's disease dementia.

Many experts now believe that Parkinson's disease dementia and dementia with Lewy bodies are two different expressions of the same underlying problems with brain processing of the protein alpha-synuclein. But most experts recommend continuing to diagnose dementia with Lewy bodies and Parkinson's dementia as separate disorders.

Guidelines for diagnosing Parkinson's disease dementia and dementia with Lewy bodies are:

Brain Imaging

Since individuals with Parkinson's are at high risk for dementia as their disease progresses, doctors monitor those with Parkinson's closely for signs of thinking changes. When someone with Parkinson's develops thinking changes, doctors often order magnetic resonance imaging (MRI) of the brain to rule out tumors, structural changes and evidence for vascular disease.

Certain factors at the time of Parkinson's diagnosis may increase future dementia risk, including older age, greater severity of motor symptoms, and having mild cognitive impairment (MCI).

Additional risk factors may include:

There are no treatments to slow or stop the brain cell damage caused by Parkinson's disease dementia. Current strategies focus on helping symptoms.

If your treatment plan includes medications, it's important to work closely with your physician to identify the drugs that work best for you and the most effective doses. Treatment considerations involving medications include the following issues:

Find a clinical trial

More than 100 research studies pertaining to Alzheimer's and other dementias are underway. Alzheimer's Association TrialMatch lets you search these trials quickly and easily. Find a trial.

Like other types of dementia that destroy brain cells, Parkinson's disease and Parkinson's disease dementia get worse over time and speed of progression can vary.

See the original post:
Parkinson's Disease Dementia | Signs, Symptoms, & Diagnosis

Here is everything you really need to know about Parkinson's Disease all in one place...

If you or someone you love suffers from Parkinson's disease, this is going to be one of the most important letters you'll ever read.

Here's why:

There's a lot of myth and misinformation floating around about Parkinson's disease.

Plus, most of the authoritative answers are written in medical language you need a medical degree to understand.

You shouldn't need to be confused about Parkinson's simply because you didn't go to medical school.

You deserve to have all the information you need in one place, written in easy-to-understand everyday language that won't confuse you. Why should you be frustrated in your attempt to find relevant and important information?

As if having Parkinson's disease or caring for someone with the disease wasn't challenging enough.)

Well, I'd like to share with you my experience which will help you a lot. So...

Read more from the original source:
Parkinson's Disease | AllAboutParkinsons.com

Parkinson's disease (PD) is a neurodegenerative brain disorder that progresses slowly in most people. Most people's symptoms take years to develop, and they live for years with the disease.

In short, a person's brain slowly stops producing a neurotransmitter called dopamine. With less and less dopamine, a person has less and less ability to regulate their movements, body and emotions.

Parkinson's disease itself is not fatal. However, complications from the disease are serious; the Center for Disease Control rated complications from PD as the 14th top cause of death in the United States.

There is currently no cure for Parkinson's. Your doctor's goal will be to treat your symptoms to keep your quality of life as high as possible. That's why your gift to the National Parkinson Foundation goes directly to research that improves the daily lives of people with PD.

Normally, there are brain cells (neurons) in the human brain that produce dopamine. These neurons concentrate in a particular area of the brain, called the substantia nigra. Dopamine is a chemical that relays messages between the substantia nigra and other parts of the brain to control movements of the human body. Dopamine helps humans to have smooth, coordinated muscle movements. When approximately 60 to 80% of the dopamine-producing cells are damaged, and do not produce enough dopamine, the motor symptoms of Parkinson's disease appear. This process of impairment of brain cells is called neurodegeneration.

The current theory (so-called Braak's hypothesis) is that the earliest signs of Parkinson's are found in the enteric nervous system, the medulla and in particular, the olfactory bulb, which controls your sense of smell. Under this theory, Parkinson's only progresses to the substantia nigra and cortex over the years. This theory is increasingly borne out by evidence that non-motor symptoms, such as a loss of sense of smell, hyposmia, sleep disorders and constipation may precede the motor features of the disease by several years. For this reason, researchers are increasingly focused on these "non-motor" symptoms to both detect PD as early as possible and to look for ways to stop its progression.

Read more from the original source:
What Is Parkinson's? | National Parkinson Foundation

Parkinson's disease (PD) is a type of movement disorder. It happens when nerve cells in the brain don't produce enough of a brain chemical called dopamine. Sometimes it is genetic, but most cases do not seem to run in families. Exposure to chemicals in the environment might play a role.

Symptoms begin gradually, often on one side of the body. Later they affect both sides. They include

As symptoms get worse, people with the disease may have trouble walking, talking, or doing simple tasks. They may also have problems such as depression, sleep problems, or trouble chewing, swallowing, or speaking.

There is no lab test for PD, so it can be difficult to diagnose. Doctors use a medical history and a neurological examination to diagnose it.

PD usually begins around age 60, but it can start earlier. It is more common in men than in women. There is no cure for PD. A variety of medicines sometimes help symptoms dramatically. Surgery and deep brain stimulation (DBS) can help severe cases. With DBS, electrodes are surgically implanted in the brain. They send electrical pulses to stimulate the parts of the brain that control movement.

NIH: National Institute of Neurological Disorders and Stroke

Read this article:
Parkinson's Disease: MedlinePlus

Most cases of Parkinson disease probably result from a complex interaction of environmental and genetic factors. These cases are classified as sporadic and occur in people with no apparent history of the disorder in their family. The cause of these sporadic cases remains unclear.

Approximately 15 percent of people with Parkinson disease have a family history of this disorder. Familial cases of Parkinson disease can be caused by mutations in the LRRK2, PARK2, PARK7, PINK1, or SNCA gene, or by alterations in genes that have not been identified. Mutations in some of these genes may also play a role in cases that appear to be sporadic (not inherited).

Alterations in certain genes, including GBA and UCHL1, do not cause Parkinson disease but appear to modify the risk of developing the condition in some families. Variations in other genes that have not been identified probably also contribute to Parkinson disease risk.

It is not fully understood how genetic changes cause Parkinson disease or influence the risk of developing the disorder. Many Parkinson disease symptoms occur when nerve cells (neurons) in the substantia nigra die or become impaired. Normally, these cells produce a chemical messenger called dopamine, which transmits signals within the brain to produce smooth physical movements. When these dopamine-producing neurons are damaged or die, communication between the brain and muscles weakens. Eventually, the brain becomes unable to control muscle movement.

Some gene mutations appear to disturb the cell machinery that breaks down (degrades) unwanted proteins in dopamine-producing neurons. As a result, undegraded proteins accumulate, leading to the impairment or death of these cells. Other mutations may affect the function of mitochondria, the energy-producing structures within cells. As a byproduct of energy production, mitochondria make unstable molecules called free radicals that can damage cells. Cells normally counteract the effects of free radicals before they cause damage, but mutations can disrupt this process. As a result, free radicals may accumulate and impair or kill dopamine-producing neurons.

In most cases of Parkinson disease, protein deposits called Lewy bodies appear in dead or dying dopamine-producing neurons. (When Lewy bodies are not present, the condition is sometimes referred to as parkinsonism.) It is unclear whether Lewy bodies play a role in killing nerve cells or if they are part of the cells' response to the disease.

Read more about the GBA, LRRK2, PARK2, PARK7, PINK1, SNCA, and UCHL1 genes.

See a list of genes associated with Parkinson disease.

Original post:
Parkinson disease - Genetics Home Reference

What is Parkinson's disease?Parkinson's disease is the second most common neurodegenerative disorder worldwide after Alzheimer's disease. Parkinson's affects nerve cells in the part of the mid-brain known as the substantia nigra, responsible for muscle movement. The result is tremors, rigidity, slow movements and difficulties with balance . Its signs and symptoms worsen over time, eventually leading to cognitive problems including dementia. But although Parkinson's may result in disability, the disease often moves slowly, and most people have a number of years of only minor disability following a diagnosis.

The motor symptoms alone are known as parkinsonism - they may be due to Parkinson's disease, or to a number of other causes that may be temporary or reversible.

The disease is named after James Parkinson, a British physician who published the first detailed description of the condition in 1817. Famous Americans including actor Michael J. Fox and boxer Muhammed Ali have the condition, and have raised awareness of it via books, appearances and interviews on behalf of groups such as the National Parkinson Foundation.

What are the causes?There appears to be a genetic component, as people with a first-degree relative who has Parkinson's, such as a parent, child or sibling, are at greater risk. In March of 2011, researchers at Mount Sinai School of Medicine published research indicating that mutations in a gene called LRRK2 are associated with the most common inherited form of the condition.

In addition, and even in people who are genetically predisposed to Parkinson's disease, many experts believe that environmental exposures, such as unusual exposure to herbicides and pesticides, increase a person's risk of developing Parkinson's disease.

Certain drugs, when taken for long periods of time or in amounts greater than recommended, can cause parkinsonism. These include medications such as Haldol (Haloperidol) and Thorazine (Chlorpromazine), used to treat psychiatric disorders, as well as drugs used to treat nausea, such as Reglan (Metoclopramide ). The anti-seizure drug, Depakene (Valproic Acid), also may cause some of the features of parkinsonism, notably severe tremor. These medications do not result in Parkinson's disease, however, and symptoms resolve when the medications are no longer used.

Who is likely to get it?Parkinson's disease generally begins in middle or late life, and the risk continues to increase as people age. Other risk factors include:

What are the symptoms?Initial symptoms may include: an arm that refuses to swing when you walk, a mild tremor in the fingers of one hand or slurred speech. You may lack energy, feel sad or have difficulty sleeping. Daily activities may take longer than normal. Other signs and symptoms can include:

How is it diagnosed?A diagnosis of Parkinson's disease is made based on medical history and a thorough neurological evaluation - there are no specific blood test or x-ray results that can definitively support the diagnosis . Your physician will inquire about any medications you take and whether you have a family member with Parkinson's. The doctor will assess your balance, walking, coordination and dexterity. Even if the symptoms are not apparent to you, a trained physician may detect subtle signs of parkinsonism - reduced facial expressions, a lack of gestures or a slight tremor.

Excerpt from:
Parkinson's Disease - Dr. Weil's Condition Care Guide

Parkinson's disease (PD) is a degenerative disorder of the central nervous system that belongs to a group of conditions called movement disorders. It is both chronic, meaning it persists over a long period of time, and progressive, meaning its symptoms grow worse over time. As nerve cells (neurons) in parts of the brain become impaired or die, people may begin to notice problems with movement, tremor, stiffness in the limbs or the trunk of the body, or impaired balance. As these symptoms become more pronounced, people may have difficulty walking, talking, or completing other simple tasks. Not everyone with one or more of these symptoms has PD, as the symptoms appear in other diseases as well.

The precise cause of PD is unknown, although some cases of PD are hereditary and can be traced to specific genetic mutations. Most cases are sporadicthat is, the disease does not typically run in families. It is thought that PD likely results from a combination of genetic susceptibility and exposure to one or more unknown environmental factors that trigger the disease.

PD is the most common form of parkinsonism[1], in which disorders of other causes produce features and symptoms that closely resemble Parkinsons disease. While most forms of parkinsonism have no known cause, there are cases in which the cause is known or suspected or where the symptoms result from another disorder.

No cure for PD exists today, but research is ongoing and medications or surgery can often provide substantial improvement with motor symptoms.

[1] Words in italics appear in a Glossary at the end of this information.

Parkinson's disease occurs when nerve cells, or neurons, in the brain die or become impaired. Although many brain areas are affected, the most common symptoms result from the loss of neurons in an area near the base of the brain called the substantia nigra. Normally, the neurons in this area produce an important brain chemical known as dopamine. Dopamine is a chemical messenger responsible for transmitting signals between the substantia nigra and the next "relay station" of the brain, the corpus striatum, to produce smooth, purposeful movement. Loss of dopamine results in abnormal nerve firing patterns within the brain that cause impaired movement. Studies have shown that most people with Parkinson's have lost 60 to 80 percent or more of the dopamine-producing cells in the substantia nigra by the time symptoms appear, and that people with PD also have loss of the nerve endings that produce the neurotransmitter norepinephrine. Norepinephrine, which is closely related to dopamine, is the main chemical messenger of the sympathetic nervous system, the part of the nervous system that controls many automatic functions of the body, such as pulse and blood pressure. The loss of norepinephrine might explain several of the non-motor features seen in PD, including fatigue and abnormalities of blood pressure regulation.

The affected brain cells of people with PD contain Lewy bodiesdeposits of the protein alpha-synuclein. Researchers do not yet know why Lewy bodies form or what role they play in the disease. Some research suggests that the cells protein disposal system may fail in people with PD, causing proteins to build up to harmful levels and trigger cell death. Additional studies have found evidence that clumps of protein that develop inside brain cells of people with PD may contribute to the death of neurons. Some researchers speculate that the protein buildup in Lewy bodies is part of an unsuccessful attempt to protect the cell from the toxicity of smaller aggregates, or collections, of synuclein.

Genetics. Scientists have identified several genetic mutations associated with PD, including the alpha-synuclein gene, and many more genes have been tentatively linked to the disorder. Studying the genes responsible for inherited cases of PD can help researchers understand both inherited and sporadic cases. The same genes and proteins that are altered in inherited cases may also be altered in sporadic cases by environmental toxins or other factors. Researchers also hope that discovering genes will help identify new ways of treating PD.

Environment. Exposure to certain toxins has caused parkinsonian symptoms in rare circumstances (such as exposure to MPTP, an illicit drug, or in miners exposed to the metal manganese). Other still-unidentified environmental factors may also cause PD in genetically susceptible individuals.

Mitochondria. Several lines of research suggest that mitochondria may play a role in the development of PD. Mitochondria are the energy-producing components of the cell and abnormalities in the mitochondria are major sources of free radicalsmolecules that damage membranes, proteins, DNA, and other parts of the cell. This damage is often referred to as oxidative stress. Oxidative stress-related changes, including free radical damage to DNA, proteins, and fats, have been detected in the brains of individuals with PD. Some mutations that affect mitochondrial function have been identified as causes of PD.

Read the original:
Parkinson's Disease: Hope Through Research: National ...

What is Parkinson's disease?

Parkinson's disease (PD) is a chronic (persistent, or long-term) disorder of part of the brain. It is named after the doctor who first described it. It mainly affects the way the brain co-ordinates the movements of the muscles in various parts of the body.

PD mainly develops in people over the age of 50. It becomes more common with increasing age. About 5 in 1,000 people in their 60s, and about 40 in 1,000 people in their 80s have PD. It affects both men and women but is a little more common in men. Rarely, it develops in people under the age of 50.

PD is not usually inherited, and it can affect anyone. However, genetic (hereditary) factors may be important in the small number of people who develop PD before the age of 50.

A small part of the brain called the substantia nigra is mainly affected. This area of the brain sends messages down nerves in the spinal cord to help control the muscles of the body. Messages are passed between brain cells, nerves and muscles by chemicals called neurotransmitters. Dopamine is the main neurotransmitter that is made by the brain cells in the substantia nigra.

If you have PD, a number of cells in the substantia nigra become damaged and die. The exact cause of this is not known. Over time, more and more cells become damaged and die. As cells are damaged, the amount of dopamine that is produced is reduced. A combination of the reduction of cells and a low level of dopamine in the cells in this part of the brain causes nerve messages to the muscles to become slowed and abnormal.

The brain cells and nerves affected in PD normally help to produce smooth, co-ordinated movements of muscles. Therefore, three common Parkinson's symptoms that gradually develop are:

The symptoms tend slowly to become worse. However, the speed in which symptoms become worse varies from person to person. It may take several years before they become bad enough to have much effect on your life. At first, one side of your body may be more affected than the other.

Some other symptoms may develop due to problems with the way affected brain cells and nerves control the muscles. These include:

Various other symptoms develop in some cases, mainly as the condition becomes worse. These include:

Read the original post:
Parkinson's Disease. Symptoms of parkinson's disease | Patient

knowledge center home parkinsons disease all about parkinsons disease what is parkinsons disease? Parkinson's disease is a progressive nervous system disorder that affects how the person moves, including how they speak and write. Symptoms develop gradually, and may start off with ever-so-slight tremors in one hand. People with Parkinson's disease also experience stiffness and find they cannot carry out movements as rapidly as before - this is called bradykinesia. The muscles of a person with Parkinson's become weaker and the individual may assume an unusual posture.

Parkinson's disease belongs to a group of conditions called movement disorders. Movement disorders describe a variety of abnormal body movements that have a neurological basis, and include such conditions as cerebral palsy, ataxia, and Tourette syndrome.

Approximately one million adults in the USA are thought to live with Parkinson's disease; over 60,000 are diagnosed annually. The real figure is probably much higher when taking into account those who go undetected. According to the Parkinson's Disease Foundation, the economic toll of the disease in the USA is nearly $25 billion annually, including direct and indirect costs. The average annual medication costs for an American with Parkinson's disease is between $2,500 and $10,000.

In the United Kingdom approximately 127,000 people have Parkinson's disease - or 1 in every 500 people. About 10 million people around the world are estimated to be living with Parkinson's disease.

A male has a 50% higher risk of developing Parkinson's disease than a female.

In the majority of cases, symptoms start to appear after the age of 50. However, in about 4% to 5% of cases the sufferer is younger than 40 years. When signs and symptoms develop in an individual aged between 21 and 40 years, it is known as Young-onset Parkinson's disease.

Apart from tremor and slow movements, the patient may also have a fixed, inexpressive face - this is because of poorer control over facial muscle coordination and movement.

Parkinson's also affects the voice - a British mathematician believes he has created a cheap and easy to carry-out test using speech signal processing algorithms to accelerate the diagnosis of Parkinson's disease. Max Little, who developed the algorithm at Oxford University, says that Parkinson's not only impacts on limb movement, but also on how people speak; on their voices. (Link to article)

Parkinson's also affects sense of smell - despite being incurable, doctors today can influence the course of the disease if Parkinson's is detected early enough; the destruction of brain cells can be slowed down - this means a better quality of life for the patient for many years. Scientists have recently discovered that hyposmia, losing one's sense of smell for no known cause, might be a marker for the non-motor signs of Parkinson's disease. The scientists said "Smelling tests in doctors' offices are suitable for detecting hyposmia, but so too are tests conducted in public places such as pedestrian zones." (Link to article)

Neurologist and co-author, co-author Brad Boeve, M.D., said:

Read this article:
Parkinson's disease - Medical News Today

Parkinson's disease facts Parkinson's disease is a neurodegenerative disorder which leads to progressive deterioration of motor function due to loss of dopamine-producing brain cells. Primary symptoms include tremor, stiffness, slowness, impaired balance, and later on a shuffling gait. Some secondary symptoms include anxiety, depression, and dementia. Most individuals with Parkinson's disease are diagnosed when they are 60 years old or older, but early-onset Parkinson's disease also occurs. With proper treatment, most individuals with Parkinson's disease can lead long, productive lives for many years after diagnosis. What is Parkinson's disease?

Parkinson's disease is the second most common neurodegenerative disorder and the most common movement disorder. It is characterized by progressive loss of muscle control, which leads to trembling of the limbs and head while at rest, stiffness, slowness, and impaired balance. As symptoms worsen, it may become difficult to walk, talk, and complete simple tasks.

The progression of Parkinson's disease and the degree of impairment vary from individual to individual. Many people with Parkinson's disease live long productive lives, whereas others become disabled much more quickly. Premature death is usually due to complications such as falling-related injuries or pneumonia.

Most individuals who develop Parkinson's disease are 60 years of age or older. Since overall life expectancy is rising, the number of individuals with Parkinson's disease will increase in the future. Adult-onset Parkinson's disease is most common, but early-onset Parkinson's disease (onset between 21-40 years), and juvenile-onset Parkinson's disease (onset before age 21) also exist.

Descriptions of Parkinson's disease date back as far as 5000 BC. Around that time, an ancient Indian civilization called the disorder Kampavata and treated it with the seeds of a plant containing therapeutic levels of what is today known as levodopa. Parkinson's disease was named after the British doctor James Parkinson, who in 1817 first described the disorder in great detail as "shaking palsy."

Medically Reviewed by a Doctor on 2/4/2015

Parkinson's Disease - Symptoms Question: At what age did Parkinson's symptoms first appear, and what are they?

Parkinson's Disease - Treatments Question: What do you do to treat and manage your Parkinson's disease?

Parkinson's Disease - Diagnosis Question: At what stage was your Parkinson's disease diagnosed?

Parkinson's Disease - Prognosis Question: Parkinson's is not a fatal disease. What is the prognosis for you, a friend, or relative?

The rest is here:
Parkinson's Disease: Get the Facts on Causes - MedicineNet

Parkinson's disease (PD, also known as idiopathic or primary parkinsonism, hypokinetic rigid syndrome (HRS), or paralysis agitans) is a degenerative disorder of the central nervous system mainly affecting the motor system. The motor symptoms of Parkinson's disease result from the death of dopamine-generating cells in the substantia nigra, a region of the midbrain. The cause of this cell death is poorly understood. Early in the course of the disease, the most obvious symptoms are movement-related; these include shaking, rigidity, slowness of movement and difficulty with walking and gait. Later, thinking and behavioral problems may arise, with dementia commonly occurring in the advanced stages of the disease, whereas depression is the most common psychiatric symptom. Other symptoms include sensory, sleep and emotional problems. Parkinson's disease is more common in older people, with most cases occurring after the age of 50; when it is seen in young adults, it is called young onset PD (YOPD).

The main motor symptoms are collectively called parkinsonism, or a "parkinsonian syndrome". The disease can be either primary or secondary. Primary Parkinson's disease is referred to as idiopathic (having no known cause), although some atypical cases have a genetic origin, while secondary parkinsonism is due to known causes like toxins. Many risks and protective factors have been investigated: the clearest evidence is for an increased risk of PD in people exposed to certain pesticides and a reduced risk in tobacco smokers. The pathology of the disease is characterized by the accumulation of a protein into Lewy bodies in neurons, and from insufficient formation and activity of dopamine in certain parts of the midbrain. Where the Lewy bodies are located is often related to the expression and degree of the symptoms of an individual. Diagnosis of typical cases is mainly based on symptoms, with tests such as neuroimaging being used for confirmation.

Treatments are effective at improving the early motor symptoms of the disease. This is typically with the medications L-DOPA and dopamine agonists. As the disease progresses and dopaminergic neurons continue to be lost, these drugs eventually become ineffective at treating the symptoms and at the same time produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms. Surgery and deep brain stimulation have been used to reduce motor symptoms as a last resort in severe cases where drugs are ineffective. Research directions include investigations into new animal models of the disease and of the potential usefulness of gene therapy, stem cell transplants and neuroprotective agents. Medications to treat non-movement-related symptoms of PD, such as sleep disturbances and emotional problems, also exist.

In 2013 PD resulted in 103,000 deaths up from 44,000 deaths in 1990.[1] The disease is named after the English doctor James Parkinson, who published the first detailed description in An Essay on the Shaking Palsy in 1817.[2] Several major organizations promote research and improvement of quality of life of those with the disease and their families. Public awareness campaigns include Parkinson's disease day (on the birthday of James Parkinson, 11 April) and the use of a red tulip as the symbol of the disease. People with parkinsonism who have increased the public's awareness of the condition include actor Michael J. Fox, Olympic cyclist Davis Phinney, and professional boxer Muhammad Ali. Parkinson's not only affects humans, but other primates as well, which have often been used in researching the disease and testing approaches to its treatment.[3][4][5]

The term parkinsonism is used for a motor syndrome whose main symptoms are tremor at rest, stiffness, slowing of movement and postural instability. Parkinsonian syndromes can be divided into four subtypes according to their origin:

Parkinson's disease is the most common form of parkinsonism and is usually defined as "primary" parkinsonism, meaning parkinsonism with no external identifiable cause.[7][8] In recent years several genes that are directly related to some cases of Parkinson's disease have been discovered. As much as this conflicts with the definition of Parkinson's disease as an idiopathic illness, genetic parkinsonism disorders with a similar clinical course to PD are generally included under the Parkinson's disease label. The terms "familial Parkinson's disease" and "sporadic Parkinson's disease" can be used to differentiate genetic from truly idiopathic forms of the disease.[9]

Usually classified as a movement disorder, PD also gives rise to several non-motor types of symptoms such as sensory deficits,[10] cognitive difficulties or sleep problems. Parkinson plus diseases are primary parkinsonisms which present additional features.[7] They include multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration and dementia with Lewy bodies.[7][11]

In terms of pathophysiology, PD is considered a synucleiopathy due to an abnormal accumulation of alpha-synuclein protein in the brain in the form of Lewy bodies, as opposed to other diseases such as Alzheimer's disease where the brain accumulates tau protein in the form of neurofibrillary tangles.[12] Nevertheless, there is clinical and pathological overlap between tauopathies and synucleinopathies. The most typical symptom of Alzheimer's disease, dementia, occurs in advanced stages of PD, while it is common to find neurofibrillary tangles in brains affected by PD.[12]

Dementia with Lewy bodies (DLB) is another synucleinopathy that has similarities with PD, and especially with the subset of PD cases with dementia. However, the relationship between PD and DLB is complex and still has to be clarified.[13] They may represent parts of a continuum or they may be separate diseases.[13]

Parkinson's disease affects movement, producing motor symptoms.[6] Non-motor symptoms, which include autonomic dysfunction, neuropsychiatric problems (mood, cognition, behavior or thought alterations), and sensory and sleep difficulties, are also common. Some of these non-motor symptoms are often present at the time of diagnosis and can precede motor symptoms.[6]

See original here:
Parkinson's disease - Wikipedia, the free encyclopedia

Parkinson's disease (PD) belongs to a group of conditions called motor system disorders, which are the result of the loss of dopamine-producing brain cells. The four primary symptoms of PD are tremor, or trembling in hands, arms, legs, jaw, and face; rigidity, or stiffness of the limbs and trunk; bradykinesia, or slowness of movement; and postural instability, or impaired balance and coordination. As these symptoms become more pronounced, patients may have difficulty walking, talking, or completing other simple tasks. PD usually affects people over the age of 60. Early symptoms of PD are subtle and occur gradually. In some people the disease progresses more quickly than in others. As the disease progresses, the shaking, or tremor, which affects the majority of people with PD may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately. Doctors may sometimes request brain scans or laboratory tests in order to rule out other diseases.

At present, there is no cure for PD, but a variety of medications provide dramatic relief from the symptoms. Usually, affected individuals are given levodopa combined with carbidopa. Carbidopa delays the conversion of levodopa into dopamine until it reaches the brain. Nerve cells can use levodopa to make dopamine and replenish the brain's dwindling supply. Although levodopa helps at least three-quarters of parkinsonian cases, not all symptoms respond equally to the drug. Bradykinesia and rigidity respond best, while tremor may be only marginally reduced. Problems with balance and other symptoms may not be alleviated at all. Anticholinergics may help control tremor and rigidity. Other drugs, such as bromocriptine, pramipexole, and ropinirole, mimic the role of dopamine in the brain, causing the neurons to react as they would to dopamine. An antiviral drug, amantadine, also appears to reduce symptoms. In May 2006, the FDA approved rasagiline to be used along with levodopa for patients with advanced PD or as a single-drug treatment for early PD.

In some cases, surgery may be appropriate if the disease doesn't respond to drugs. A therapy called deep brain stimulation (DBS) has now been approved by the U.S. Food and Drug Administration. In DBS, electrodes are implanted into the brain and connected to a small electrical device called a pulse generator that can be externally programmed. DBS can reduce the need for levodopa and related drugs, which in turn decreases the involuntary movements called dyskinesias that are a common side effect of levodopa. It also helps to alleviate fluctuations of symptoms and to reduce tremors, slowness of movements, and gait problems. DBS requires careful programming of the stimulator device in order to work correctly.

PD is both chronic, meaning it persists over a long period of time, and progressive, meaning its symptoms grow worse over time. Although some people become severely disabled, others experience only minor motor disruptions. Tremor is the major symptom for some individuals, while for others tremor is only a minor complaint and other symptoms are more troublesome. It is currently not possible to predict which symptoms will affect an individual, and the intensity of the symptoms also varies from person to person.

The National Institute of Neurological Disorders and Stroke (NINDS) conducts PD research in laboratories at the National Institutes of Health (NIH) and also supports additional research through grants to major medical institutions across the country. Current research programs funded by the NINDS are using animal models to study how the disease progresses and to develop new drug therapies. Scientists looking for the cause of PD continue to search for possible environmental factors, such as toxins, that may trigger the disorder, and study genetic factors to determine how defective genes play a role. Other scientists are working to develop new protective drugs that can delay, prevent, or reverse the disease.

Originally posted here:
Parkinson's Disease Information Page: National Institute ...

Using Deep Brain Stimulation Surgery to Help Ease Parkinson #39;s Symptoms
At JFK Medical Center in Edison, doctors use deep brain stimulation surgery to stop tremors that plague patients with Parkinson #39;s disease. Don #39;t forget to SUBSCRIBE for daily videos: http://bit....

By: NJTV News

Read more:
Using Deep Brain Stimulation Surgery to Help Ease Parkinson's Symptoms - Video

Personalized Medicine and Disease Course Modification in Parkinson #39;s Disease - Amos Korczyn

By: Amos Korczyn

Here is the original post:
Personalized Medicine and Disease Course Modification in Parkinson's Disease - Amos Korczyn - Video